Reproductive performance of dairy cows with delayed uterine involution under hormonal therapy with estradiol cypionate and estradiol benzoate
DOI:
https://doi.org/10.15381/rivep.v28i1.12943Keywords:
delayed uterine involution, dairy cows, treatment, reproductive performanceAbstract
The aim of this study was to evaluate the reproductive performance of dairy cows with delayed uterine involution under hormonal treatment with estradiol cypionate (CE2) and estradiol benzoate (BE2) between 36 and 49 days after parturition and a group of dairy cows with normal uterine involution. A total of 349 dairy cows with delayed uterine involution and 127 dairy cows without delayed uterine involution from a commercial farm in Lima, Peru were used. The BE2 treatment consisted of the i.m. application of 3 doses of 5 mg at 2-day interval and the CE2 treatment consisted of the i.m. application of 2 doses of 4 mg at 4-day interval. The parameters evaluated were calving-to-conception interval (IPC), services per conception (NSC), conception rate at first service (P1S) and the pregnancy rate at 200 days (P200D). In addition, the likelihood of get pregnant according to the days in lactation using Cox proportional hazards model. Both the IPC and the NSC were lower in cows treated with CE2 (122.1 days and 1.3 respectively) that in cows treated with BE2 (138.4 days and 1.5, respectively (p<0.05). The P1S and P200D were similar in cows with CE2 (49.3 and 47.7% respectively) and in cows treated with BE2 (36.7 and 50.2% respectively). In addition, cows treated with CE2 were 1.6 times more likely to conceive sooner than cows treated with BE2 (p<0.01). The application of estradiol cypionate in relation to oestradiol benzoate is recommended to improve the reproductive performance in dairy cows with delayed uterine involution.
Downloads
Downloads
Published
Issue
Section
License
Copyright (c) 2017 Luis Felipe Ruiz García, Rocío Silvia Sandoval Monzón, Milena Montenegro Vega, Alfredo Delgado Castro
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
AUTHORS RETAIN THEIR RIGHTS:
a. Authors retain their trade mark rights and patent, and also on any process or procedure described in the article.
b. Authors retain their right to share, copy, distribute, perform and publicly communicate their article (eg, to place their article in an institutional repository or publish it in a book), with an acknowledgment of its initial publication in the Revista de Investigaciones Veterinarias del Perú (RIVEP).
c. Authors retain theirs right to make a subsequent publication of their work, to use the article or any part thereof (eg a compilation of his papers, lecture notes, thesis, or a book), always indicating the source of publication (the originator of the work, journal, volume, number and date).
